Application Nr Approved Date Route Status External Links
NDA019806 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Semprex-D Capsules Are Indicated For Relief Of Symptoms Associated With Seasonal Allergic Rhinitis Such As Sneezing, Rhinorrhea, Pruritus, Lacrimation, And Nasal Congestion. Semprex-D Capsules Should Be Administered When Both The Antihistaminic Activity Of Acrivastine And The Nasal Decongestant Activity Of Pseudoephedrine Are Desired (see Clinical Pharmacology ). The Efficacy Of Semprex-D Capsules Beyond 14 Days Of Continuous Treatment In Patients With Seasonal Allergic Rhinitis Has Not Been Adequately Investigated In Clinical Trials. Semprex-D Capsules Have Not Been Adequately Studied For Effectiveness In Relieving The Symptoms Of The Common Cold.

All Formulated Excipients (0 Total)


Active Ingredients ( 2 Total)